We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Brain Tumors Grow by Tapping Preexisting Blood Vessels for Nutrients

By LabMedica International staff writers
Posted on 24 Aug 2014
Findings from a new study on how tumors grow and spread in the brain may cause cancer researchers to rethink treatment options based on drugs that block angiogenesis.

According to the angiogenesis theory, tumors that are more than one cubic millimeter in size need to attract or grow their own blood vessels to survive. More...
This theory led to clinical trials with anti-angiogenesis drugs such as bevacizumab and DC101. However, such clinical trials have failed to produce evidence of reduced tumor growth or increased patient survival.

Investigators at the University of Michigan (Ann Arbor, USA) examined this phenomenon in rodents and human cancer patients and by advanced computer modeling.

They reported in the July 2014 issue of the journal Neoplasia that implanted rodent and human brain cancer cells commonly invaded and proliferated within the brain perivascular space. This form of brain tumor growth and invasion was also shown to characterize de novo generated endogenous mouse brain tumors, biopsies of primary human glioblastoma, and peripheral cancer metastasis to the human brain.

Perivascularly invading brain tumors became vascularized by normal brain microvessels when individual glioma cells used perivascular space as a conduit for tumor invasion. Since the cancer cells were obtaining blood from already existing vascular tissues, their growth and spread were not impeded by treatment with antiangiogenic agents.

The experimental findings showing that tumor perivascular spreading was independent of growth of new blood vessels had been predicted by computational modeling. The investigators tested this prediction experimentally by blocking angiogenic signaling using antibodies targeting the VEGF-A (vascular endothelial growth factor) signaling axis. VEGF-A inhibitors failed to block progressive tumor growth or extend median survival in multiple brain tumor models.

"The key question has been to determine how tumor-generating cells grow to form the macroscopic tumor mass that eventually kills the patients," said senior author Dr. Pedro Lowenstein, professor of neurosurgery and cell and developmental biology at the University of Michigan. "We have shown that because of the very high density of endogenous vessels in the brain and central nervous system, the cells grow along those preexisting vessels and eventually divide to fill the space between them, where the distance between any two vessels is very small. This iterative growth along vessels and into the space between means the tumor does not grow like a balloon requiring new vessels to grow into its expanding mass to rescue it, but rather as an accumulation of local small masses which then coalesce into a large tumor."

Related Links:

University of Michigan



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Gastrointestinal Panel
Xpert® GI Panel
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: (a) CTC separation using contraction-expansion inertial microfluidics. (b) CTC detection using the YOLOv8 deep learning model. (Image Credit: Junyi Ouyang, Haiqin Li)

Label-Free Platform Combines Microfluidics and AI for Circulating Tumor Cell Analysis

Liquid biopsy relies on detecting rare tumor-derived material in blood, but circulating tumor cells (CTCs) are especially difficult to capture because they are vastly outnumbered by normal blood cells.... Read more

Molecular Diagnostics

view channel
Image: Congenital cytomegalovirus can go unnoticed at birth despite later risks to hearing and development (Image Credit: 123RF)

Pooled Saliva PCR Screening Identifies Congenital CMV Missed by Targeted Testing

Congenital cytomegalovirus (cCMV) can be present in newborns who appear healthy and pass routine hearing screening. The infection is one of the most common maternal-to-fetal infections during pregnancy... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.